Founderpath vs venture capital
Venture capital gives you cash for a share of your company, with no repayment but with investor rights such as board seats and a liquidation preference. Founderpath's revenue financing and term loans are repaid from revenue over 12-48 months and take no equity, warrants or board seat.
Key takeaways
- Median dilution across seed to Series C rounds fell from about 18% to 16% during 2025, according to Carta’s 2025 review (Carta, February 18, 2026).
- The median founding team owns about 56% of the company after its seed round and 36% after its Series A, per Carta’s Founder Ownership Report 2026 (Carta, March 12, 2026).
- In Cooley’s Q2 2026 Venture Financing Report, 95.8% of deals carried a 1x liquidation preference and 96.4% used nonparticipating preferred stock (Cooley, August 17, 2026).
- Only 0.6% of entrepreneurs started with venture capital, per Kauffman Foundation calculations from the Census Bureau’s 2014 Annual Survey of Entrepreneurs (Kauffman Foundation, December 5, 2016).
- Founderpath revenue financing starts at a 7% annual discount over 12-36 months, and its term loans at 15% annual interest for up to 48 months, with no equity, warrants or board seat (Founderpath product pages, checked October 20, 2026).
TL;DR
Equity or repayment
Venture terms below are market data, not one firm's offer. Founderpath terms are its own published statements on its revenue financing and term loan pages. Final terms on either side come from your term sheet.
| Venture capital | Founderpath revenue financing | Founderpath term loan | |
|---|---|---|---|
| What you give | Shares of preferred stock; Carta’s 2025 median was about 16% per round (Carta, February 18, 2026) | A share of future receivables; no equity or warrants | A loan secured on business assets; no equity or warrants |
| Repayment | None; investors are paid when the company is sold or lists | Fixed monthly payments over 12-36 months | Monthly over up to 48 months, interest-only for up to 24 |
| Price | Unknown until exit: the stake’s share of the sale | Annual discount from 7%, on the workbook formula | Annual interest from 15%; confirm fees in the offer |
| Control | Investor-elected directors, protective provisions, drag-along | No board seat | No board seat |
| Sale or early exit | In Cooley’s Q2 2026 sample, 95.8% of deals had a 1x liquidation preference. (Cooley, August 17, 2026) | Repay early at any time to save the remaining discount | No prepayment penalty |
| Who it fits | Companies aiming for outcomes cash flow cannot fund, including pre-revenue | Software companies around $1M-$3M ARR | Software companies, most above $3M in annual revenue |
| Timing | Among Carta companies that raised a Series A in Q2 2025, the median seed-to-Series-A interval was 616 days. (Carta, September 19, 2025) | Funds usually within 24 hours of accepting | Most close in under four weeks after data connection |
How much equity a VC round costs
In a priced round the investor's share is its check divided by the post-money valuation. A $1M check at a $4M pre-money valuation makes a $5M post-money, so the investor owns 20%. Carta reports that median dilution across seed to Series C rounds fell from about 18% to 16% during 2025, and that the median Series A in Q1 2025 sold 17.9%, down from 20.9% a year earlier.
Dilution compounds because each round sells a share of what is left. Your ownership after a round is your ownership before it × (1 - share sold): sell 20% at seed and 20% at Series A and a founder who started with 100% holds 64%, before any option pool. Across companies on its platform, Carta finds the median founding team holds about 56% after seed and 36% after Series A (rounds raised 2021-2025).
A share of a company has no fixed price. What the stake costs you is what it is worth when investors are paid, which is why the calculator below asks for your own exit assumption rather than converting equity into a dollar cost.
The rights that come with the money
Liquidation preference
Preferred stock is paid before common stock when the company is sold. With a 1x non-participating preference the investor takes the larger of its money back or its percentage of the sale. That is the common structure: in Cooley's Q2 2026 report, 95.8% of deals had a 1x preference and 96.4% used nonparticipating preferred.
Worked example: an investor pays $1M for 20%. If the company sells for $3M, its 20% is worth $600K, so it takes the $1M preference and $2M is left for everyone else. If the company sells for $50M, it converts and takes $10M, leaving $40M.
Board seats and control
The NVCA model documents used as the starting point for many US rounds include a Voting Agreement, which sets board appointment rights and drag-along rights. Wilson Sonsini's 2024 financing primer describes directors elected by a specific preferred series, protective provisions listing actions the company cannot take without stockholder approval, and preemptive rights often limited to major investors.
“The valuation matters a lot less than all the other things you negotiate: the 1X liquidation preference, the control and the structure of the board, very, very important. … What I'm very proud of is that we never really took a crazy valuation. We always made sure that we have good composition and control of the board.”
Ownership sold vs total repayment
Enter your own numbers. The 16% default is Carta's median dilution across seed to Series C rounds in 2025 (Carta, February 2026). The 7% discount and 15% annual interest are Founderpath's published starting terms, checked October 20, 2026. The exit value starts blank because only you can assume it, and the loan fee starts blank because Founderpath's term-loan page and its workbook disagree on fees.
Venture capital round
- Ownership sold
- 16%
- Your ownership after the round
- 84%
- Implied post-money valuation
- $3,125,000.00
- Repayment
- None
- At exit
- Enter an exit value to see who receives what.
Founderpath revenue financing
- Ownership sold
- 0%
- Monthly payment
- $24,224.81
- Total repayment
- $581,395.35
- Cost above cash received
- $81,395.35
- Upfront fee withheld
- $0.00
- Repayment period
- 24 months
Founderpath term loan
No result: complete the inputs within the limits below.
Modeled for $500K-$10M gross principal and up to 48 months, as published. Interest-only periods are not modeled. Enter the fee from your offer, including zero.How the numbers are calculated
- Post-money valuation = cash / share sold. Pre-money = post-money - cash.
- Your ownership after the round = ownership before × (1 - share sold).
- Investor at exit (1x non-participating) = the larger of its cash back (capped at the exit value) and share sold × exit value. Everyone else shares the rest.
- Founderpath RPA repayment = cash / (1 - annual discount × months / 12), from the receivables workbook.
- Term-loan payments apply annual interest / 12 to the declining balance. A quoted upfront fee is withheld, so principal is grossed up to deliver the same cash. This is annual interest, not an APR.
The results are separate quantities and are not netted against each other. Equity has no repayment, but its cost depends on what the company is worth when investors are paid. Debt has a known repayment that you fund from cash flow, and it requires revenue to qualify. Neither result is an offer.
When each one makes sense
Venture capital
Fits a company that needs more capital than its revenue can repay, including pre-revenue companies, and whose founders want an outcome large enough to share. Expect to raise again: Carta's median gap from seed to Series A reached 616 days in Q2 2025. Few companies take this route: Kauffman Foundation calculations from Census data found that 0.6% of entrepreneurs initially received venture capital.
Non-dilutive capital
Fits a company with recurring revenue that can carry a fixed monthly payment and wants to keep its ownership and board. Founderpath's non-dilutive funding guide lists pre-revenue startups and companies actively raising a VC round as not a fit, as of October 2026. Other non-dilutive lenders compared on this site include Capchase, Lighter Capital, SaaS Capital, Pipe and SVB; the full list sets out their models and terms.
See what your revenue qualifies for before you decide on a round.
Check your Founderpath offerWhat Founderpath publishes
From Founderpath's revenue financing and term loan pages, checked October 20, 2026.
- Revenue financing
- Annual discount from 7%, fixed monthly payments over 12-36 months; most rounds up to $1.5M. Usually funded within 24 hours of accepting.
- Term loans
- $500K-$10M at annual interest from 15%, up to 48 months with up to 24 months interest-only. Most close in under four weeks.
- Not required
- Equity, warrants or board seats. Security is a lien on business assets.
- Personal guarantee
- Listed as none in the product terms tables; the product FAQs say no full personal guarantee. Confirm in your agreement.
Founderpath's published entry guidance is $10K MRR, about $120K ARR, in its non-dilutive funding guide, while its live product pages show a $500K last-year revenue line and target about $1M-$3M ARR for revenue financing. These are not one consistent minimum; confirm eligibility for your product. The term-loan page says there are no origination fees, while its linked workbook models a 2% original issue discount, so confirm fees in your offer.
Founderpath's live funding data reports $286M wired across 765 funded deals.
Source updated November 5, 2026. Deals are not a count of unique founders.Read the sources behind the numbers
This is a Founderpath-authored comparison. Venture figures are market medians from the named publishers, not the terms of any one firm. Founderpath terms are its own published statements. Every source below was checked on October 20, 2026. The calculator illustrates arithmetic on your inputs; it is not an offer and does not show that either option costs less.
- Carta, State of Private Markets: 2025 in Review (February 18, 2026)
- Carta, State of Private Markets: Q1 2025 (May 13, 2025)
- Carta, Founder Ownership Report 2026 (March 12, 2026)
- Carta, Series A Funding Slides in Q2 2025 (September 19, 2025)
- Carta, Fund Economics Report 2025 (December 4, 2025)
- Cooley, Q2 2026 Venture Financing Report (August 17, 2026)
- NVCA, Model Legal Documents (Voting Agreement updated June 2026)
- Baker Donelson, NVCA Revises Model Forms (May 30, 2024)
- Wilson Sonsini, VC Financing Fundamentals (2024)
- Kauffman Foundation, Annual Survey of Entrepreneurs briefing (December 5, 2016)
- Kauffman Foundation, Capital Access Lab
- Founderpath, revenue financing terms
- Founderpath, term loan terms
- Founderpath, product overview (sizes and terms)
- Founderpath, non-dilutive funding guide (entry guidance and fit)
- Founderpath, receivables purchase workbook
- Founderpath, term-loan workbook
- Founderpath, live funding statistics
No. Founderpath provides revenue financing, term loans and merchant cash advances that are repaid over a fixed term. Its product pages state, as of October 2026, that it takes no equity, warrants or board seats, so funding from Founderpath does not give it stock in your company. Source
It varies by round and company. Carta reports that median dilution across seed to Series C rounds fell from about 18% to 16% during 2025, and that the median Series A in Q1 2025 sold 17.9% of the company. Source
Multiply your ownership before the round by one minus the share sold. If you own 100% and sell 20%, you keep 80%; sell another 20% in the next round and you keep 64%. The investor’s share is its investment divided by the post-money valuation, which is the pre-money valuation plus the new cash. Source
At a sale, the investor chooses the larger of getting its investment back first or converting to common shares and taking its percentage. In Cooley’s Q2 2026 report, 95.8% of deals had a 1x preference and 96.4% used nonparticipating preferred stock. Source
Often, yes. The NVCA model Voting Agreement sets out board appointment rights and drag-along rights, and Wilson Sonsini’s 2024 financing primer describes directors elected by a specific preferred series. The exact board terms are negotiated in each round. Source
Not in every case, and no single number settles it. Debt has a known repayment funded from cash flow. Equity has no repayment, but its cost is the share of the sale price investors receive, which depends on an exit value nobody knows in advance. The calculator on this page shows both for the same cash. Source
Very few. Kauffman Foundation calculations from the Census Bureau’s 2014 Annual Survey of Entrepreneurs found that 0.6% of entrepreneurs initially received venture capital. Its Capital Access Lab puts venture capital use at 0.5% of entrepreneurs. Source
Founderpath’s non-dilutive funding guide lists companies actively raising a VC round as not a fit, as of October 2026. If you already have investors, check your charter and investor agreements for consent rights before you take on any financing. Source
Keep your equity and see what your revenue qualifies for.
Get your Founderpath offer